Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription Articles published in Circulation Retrieve available abstracts of 251 articles: HTML format

Single Articles

July 2024
1. HEIJMAN J, Dobrev D
   Spexin Hormone Signaling and Atrial Fibrillation: The Knowns and Unknowns.
   Circulation. 2024;150:128-131.
   PubMed    
   
   
   
2. VAN DOORN S, Rutten FH, Geersing GJ
   Response by van Doorn et al to Letters Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled
   Circulation. 2024;150:e30-e32.
   PubMed    
   
   
   
3. KO D, Kim DH, Singer DE
   Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e25-e26.
   PubMed    
   
   
   
4. SUWA M, Morii I, Kino M
   Letter by Suwa et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e27.
   PubMed    
   
   
   
5. MILLIS CE, Feradov DF, Prida XE
   Letter by Millis et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e23-e24.
   PubMed    
   
   
   
6. LIN Y
   Letter by Lin Regarding Article, "Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e21-e22.
   PubMed    
   
   
   
7. KOHSAKA S, Nishimura S, Kumamaru H
   Letter by Kohsaka et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
   Circulation. 2024;150:e28-e29.
   PubMed    
   
   
   
8. ORAL H, Morady F
   Ablation of Cardiac Arrhythmias: Past, Present, and Future.
   Circulation. 2024;150:4-6.
   PubMed    
   
   
   
9. 
   Correction to: Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial.
   Circulation. 2024;150:e20.
   PubMed    
   
   
   June 2024
10. PEIGH G, Zhou J, Rosemas SC, Roberts AI, et al
    Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069757.
    PubMed     Abstract available
    
    
    
11. CROTTI L, Neves R, Dagradi F, Musu G, et al
    Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.068959.
    PubMed     Abstract available
    
    
    
12. FAKUADE FE, Hubricht D, Moller V, Sobitov I, et al
    Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation.
    Circulation. 2024 Jun 24. doi: 10.1161/CIRCULATIONAHA.123.066577.
    PubMed     Abstract available
    
    
    
13. GROUSSIN P, Melot A, Martins RP
    PVC or Not PVC? That Is the Question.
    Circulation. 2024;149:1927-1930.
    PubMed    
    
    
    
14. 
    Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e1413.
    PubMed    
    
    
    
15. LEE CH, Higgs E, Scheinman MM
    A Wide Complex Tachycardia.
    Circulation. 2024;149:1852-1854.
    PubMed    
    
    
    May 2024
16. ENSAM B, Scrocco C, Johnson D, Wijeyeratne YD, et al
    Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial.
    Circulation. 2024;149:1693-1695.
    PubMed    
    
    
    
17. ROHNER R, Kneihsl M, Goeldlin MB, Hakim A, et al
    Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized-controlled ELAN Trial.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.124.069324.
    PubMed     Abstract available
    
    
    
18. MAHESH M, Mantoo MR, Makkar N
    Left Ventricular Hypertrophy With Preexcitation.
    Circulation. 2024;149:1614-1616.
    PubMed    
    
    
    
19. LI D, Liu Y, Li C, Zhou Z, et al
    Spexin Diminishes Atrial Fibrillation Vulnerability by Acting on Galanin Receptor 2.
    Circulation. 2024 May 10. doi: 10.1161/CIRCULATIONAHA.123.067517.
    PubMed     Abstract available
    
    
    April 2024
20. MAYER M
    Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1109-e1110.
    PubMed    
    
    
    
21. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1111-e1112.
    PubMed    
    
    
    
22. CHUGH SS
    Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators.
    Circulation. 2024;149:1059-1061.
    PubMed    
    
    
    March 2024
23. PATEL SM, Ruff CT
    Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
    Circulation. 2024;149:989-992.
    PubMed    
    
    
    
24. REIFFEL JA
    Atrial Fibrillation: Why Are We Hiding Reality?
    Circulation. 2024;149:979-980.
    PubMed    
    
    
    
25. LEE CH, Scheinman MM
    Wide Complex Tachycardia: Mind Your Medicine!
    Circulation. 2024;149:963-966.
    PubMed    
    
    
    
26. KOWEY PR, Naccarelli GV
    Antiarrhythmic Drug Therapy: Where Do We Go From Here?
    Circulation. 2024;149:801-803.
    PubMed    
    
    
    
27. KLEIMAN NS, Goel SS
    The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World?
    Circulation. 2024;149:744-746.
    PubMed    
    
    
    
28. BATRA AS, Silka MJ, Borquez A, Cuneo B, et al
    Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).
    Circulation. 2024;149:e937-e952.
    PubMed     Abstract available
    
    
    February 2024
29. 
    Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e936.
    PubMed    
    
    
    
30. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
    mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
    Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
    PubMed     Abstract available
    
    
    
31. LIN AE, Bapat AC, Xiao L, Niroula A, et al
    Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
    Circulation. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065597.
    PubMed     Abstract available
    
    
    
32. SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al
    Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias.
    Circulation. 2024;149:475-480.
    PubMed    
    
    
    
33. GALEA R, Meneveau N, De Marco F, Aminian A, et al
    One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2024;149:484-486.
    PubMed    
    
    
    January 2024
34. LEE SY, Lee BK
    Palpitations and Recurrent Syncope in a Young Woman.
    Circulation. 2024;149:402-405.
    PubMed    
    
    
    
35. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
    Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Circulation. 2024;149:379-390.
    PubMed     Abstract available
    
    
    
36. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    PubMed     Abstract available
    
    
    
37. WALLENTIN L, Giugliano RP
    Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Circulation. 2024;149:290-292.
    PubMed    
    
    
    
38. BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al
    A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
    Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804.
    PubMed     Abstract available
    
    
    
39. 
    Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e167.
    PubMed    
    
    
    December 2023
40. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    PubMed     Abstract available
    
    
    
41. BERGEMAN AT, Lieve KVV, Kallas D, Bos JM, et al
    Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2023;148:2029-2037.
    PubMed     Abstract available
    
    
    
42. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
    Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
    Circulation. 2023;148:1932-1944.
    PubMed     Abstract available
    
    
    
43. KATAOKA N, Imamura T, Kinugawa K
    Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)".
    Circulation. 2023;148:1914.
    PubMed    
    
    
    November 2023
44. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023 Nov 30. doi: 10.1161/CIR.0000000000001193.
    PubMed     Abstract available
    
    
    
45. KHIDHIR A, Curtis AB
    Perspective on ACC/AHA/ACCP/HRS Guidelines for the Management of Atrial Fibrillation.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066919.
    PubMed    
    
    
    
46. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    PubMed     Abstract available
    
    
    
47. HIGUCHI S, Voskoboinik A, Il Im S, Lee A, et al
    Frequent Premature Atrial Contractions Lead to Adverse Atrial Remodeling and Atrial Fibrillation in a Swine Model.
    Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.065874.
    PubMed     Abstract available
    
    
    
48. GONZALEZ-TORRECILLA E, Luna Lopez R, Avila Alonso P
    Atrioventricular Block: Does This Patient Require a Pacemaker?
    Circulation. 2023;148:1725-1727.
    PubMed    
    
    
    
49. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
    Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
    Circulation. 2023;148:1691-1704.
    PubMed     Abstract available
    
    
    
50. QI M, Ma S, Liu J, Liu X, et al
    In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice.
    Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.065624.
    PubMed     Abstract available
    
    
    
51. WILDE AAM, Saenen J
    Risk Stratification in Brugada Syndrome: How Low Can We Go?
    Circulation. 2023;148:1556-1558.
    PubMed    
    
    
    
52. BELBACHIR N, Wu Y, Shen M, Zhang SL, et al
    Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells.
    Circulation. 2023;148:1598-1601.
    PubMed    
    
    
    
53. KIM MC, Lim Y, Lee SH, Shin Y, et al
    Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
    Circulation. 2023;148:1570-1581.
    PubMed     Abstract available
    
    
    
54. GAITA F, Cerrato N, Giustetto C, Martino A, et al
    Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study.
    Circulation. 2023;148:1543-1555.
    PubMed     Abstract available
    
    
    
55. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    PubMed    
    
    
    
56. MCINTYRE WF, Benz AP, Becher N, Healey JS, et al
    Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512.
    PubMed     Abstract available
    
    
    
57. POKORNEY SD, Granger CB
    The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease.
    Circulation. 2023;148:1455-1458.
    PubMed    
    
    
    October 2023
58. STEVENSON WG, Tandri H, Roden DM
    The Shape of Ventricular Tachycardia.
    Circulation. 2023;148:1368-1370.
    PubMed    
    
    
    
59. NISHIMURA T, Shatz N, Weiss JP, Zawaneh M, et al
    Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit.
    Circulation. 2023;148:1354-1367.
    PubMed     Abstract available
    
    
    
60. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    PubMed     Abstract available
    
    
    
61. O'HARA PE, Venkatesh V, Lehrenbaum H
    A Unique Case of Right Axis Deviation.
    Circulation. 2023;148:1261-1262.
    PubMed    
    
    
    
62. KRISAI P, Kuhne M, Sticherling C
    Letter by Krisai et al Regarding Article, "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial".
    Circulation. 2023;148:1182.
    PubMed    
    
    
    
63. BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al
    Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Circulation. 2023;148:1179-1181.
    PubMed    
    
    
    September 2023
64. PARKASH R, O'Meara E, Tang ASL
    The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial Fibrillation and Heart Failure.
    Circulation. 2023;148:933-935.
    PubMed    
    
    
    
65. EZEKOWITZ MD, Kamareddine M
    Filling an Important Knowledge Gap: The DOAC Score.
    Circulation. 2023;148:947-949.
    PubMed    
    
    
    
66. PERERA D, Morgan HP, Ryan M, Dodd M, et al
    Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Circulation. 2023;148:862-871.
    PubMed     Abstract available
    
    
    
67. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
    Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
    Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
    PubMed     Abstract available
    
    
    
68. PUNDI K, Marcus GM, Turakhia M
    The Epidemic and Data-Free Zone of Nonsustained Ventricular Tachycardia: An Unintended Consequence of Digital Monitoring and a Path Forward.
    Circulation. 2023;148:805-807.
    PubMed    
    
    
    
69. XIAO SY, Goldschlager N, Durstenfeld MS
    Chest Pain, Bundle Branch Block, and Wide Complex Tachycardia: Is Three a Company or Crowd?
    Circulation. 2023;148:845-847.
    PubMed    
    
    
    August 2023
70. JOOSTEN LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485.
    PubMed     Abstract available
    
    
    
71. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
    Circulation. 2023 Aug 25. doi: 10.1161/CIRCULATIONAHA.123.064556.
    PubMed    
    
    
    
72. MUSTROPH J, Baier MJ, Unsin D, Provaznik Z, et al
    Ethanol-Induced Atrial Fibrillation Results From Late I(Na) and Can Be Prevented by Ranolazine.
    Circulation. 2023;148:698-700.
    PubMed    
    
    
    
73. ALGALARRONDO V, Extramiana F
    Autoimmune Atrial Fibrillation or Atrial Fibrillation-Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?
    Circulation. 2023;148:499-501.
    PubMed    
    
    
    
74. JIAO T, Ruzieh M
    Letter by Jiao and Ruzieh Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:508-509.
    PubMed    
    
    
    
75. RAJJOUB K, Rajjoub EA, Ramos-Jimenez J
    What Is the Mechanism of the Premature Beats?
    Circulation. 2023;148:426-429.
    PubMed    
    
    
    July 2023
76. VAZQUEZ E, Vazquez-Sanchez T, Sanchez-Perales C
    Letter by Vazquez et al Regarding Article, "Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial".
    Circulation. 2023;148:378.
    PubMed    
    
    
    
77. YOUNIS A, Ali S, Hsich E, Goldenberg I, et al
    Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator.
    Circulation. 2023;148:241-252.
    PubMed     Abstract available
    
    
    
78. AL-KHATIB SM, Thomas KL
    Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients.
    Circulation. 2023;148:253-255.
    PubMed    
    
    
    
79. HAISSAGUERRE M, Duchateau J, Laredo M, Lavergne T, et al
    Inducibility of Short-Coupled Purkinje Ectopy by Pharmacological Tests in Patients With Spontaneous Short-Coupled Idiopathic Ventricular Fibrillation.
    Circulation. 2023;148:70-72.
    PubMed    
    
    
    
80. MAGUY A, Mahendran Y, Tardif JC, Busseuil D, et al
    Autoimmune Atrial Fibrillation.
    Circulation. 2023 Jul 4. doi: 10.1161/CIRCULATIONAHA.122.062776.
    PubMed     Abstract available
    
    
    June 2023
81. HOCHSTADT A, Geist M, Viskin S
    Occam's Razor: Two Arrhythmias in a Single Heart?
    Circulation. 2023;147:1779-1781.
    PubMed    
    
    
    
82. COULT J, Yang BY, Kwok H, Kutz JN, et al
    Prediction of Shock-Refractory Ventricular Fibrillation During Resuscitation of Out-of-Hospital Cardiac Arrest.
    Circulation. 2023 Jun 2. doi: 10.1161/CIRCULATIONAHA.122.063651.
    PubMed     Abstract available
    
    
    May 2023
83. DOUNDOULAKIS I, Tsioufis K, Gatzoulis KA
    Letter by Doundoulakis et al Regarding Article, "Programmed Ventricular Stimulation as Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy".
    Circulation. 2023;147:1714.
    PubMed    
    
    
    
84. MILES C, Boukens BJ, Scrocco C, Wilde AAM, et al
    Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
    Circulation. 2023;147:1622-1633.
    PubMed     Abstract available
    
    
    
85. VISKIN S, Rosso R
    Treatment of Brugada Syndrome in 2023: Know Where You Come From to Know Where You Are Going.
    Circulation. 2023;147:1579-1581.
    PubMed    
    
    
    
86. NADEMANEE K, Chung FP, Sacher F, Nogami A, et al
    Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Circulation. 2023;147:1568-1578.
    PubMed     Abstract available
    
    
    
87. TURAGAM MK, Neuzil P, Schmidt B, Reichlin T, et al
    Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064959.
    PubMed     Abstract available
    
    
    
88. RUSSO AM
    Pulsed Field Ablation: Is It Better Than Conventional Thermal Ablation for Treatment of Atrial Fibrillation?
    Circulation. 2023;147:1433-1435.
    PubMed    
    
    
    
89. GUPTA AR, Deshmukh AJ, Del-Carpio Munoz F
    A Tale of Two Parallel Rhythms.
    Circulation. 2023;147:1463-1466.
    PubMed    
    
    
    
90. DUAN H, Zhang CH
    A Series of Abnormal ECGs: Are They Benign or Sinister?
    Circulation. 2023;147:1407-1410.
    PubMed    
    
    
    
91. WANG Y, Wang J, Shi L, Chen X, et al
    CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling.
    Circulation. 2023 May 2. doi: 10.1161/CIRCULATIONAHA.122.062660.
    PubMed     Abstract available
    
    
    April 2023
92. 
    Correction to: Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:e717.
    PubMed    
    
    
    
93. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Effects of Systematic Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: a Secondary Analysis of the Randomized LOOP Study.
    Circulation. 2023 Apr 15. doi: 10.1161/CIRCULATIONAHA.123.064361.
    PubMed     Abstract available
    
    
    
94. HARRINGTON J, Carnicelli AP, Hua K, Wallentin L, et al
    Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Circulation. 2023 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.062752.
    PubMed     Abstract available
    
    
    
95. KIM JU, Bray J, Ahmad M
    Letter by Kim et al Regarding Article, "Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study".
    Circulation. 2023;147:1186-1187.
    PubMed    
    
    
    March 2023
96. BAPAT A, Schloss MJ, Yamazoe M, Grune J, et al
    A Mouse Model of Atrial Fibrillation in Sepsis.
    Circulation. 2023;147:1047-1049.
    PubMed    
    
    
    
97. CHYOU JY, Barkoudah E, Dukes JW, Goldstein LB, et al
    Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 13. doi: 10.1161/CIR.0000000000001133.
    PubMed     Abstract available
    
    
    
98. HYDES TJ, Lip GYH, Lane DA
    Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease.
    Circulation. 2023;147:795-797.
    PubMed    
    
    
    
99. FRIEDMAN DJ, Al-Khatib SM, Dalgaard F, Fudim M, et al
    Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2023;147:812-823.
    PubMed     Abstract available
    
    
    
100. VERMA A, Haines DE, Boersma LV, Sood N, et al
     Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.
     Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.123.063988.
     PubMed     Abstract available
     
     
     February 2023
101. CONWAY J, Min S, Villa C, Weintraub RG, et al
     The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
     Circulation. 2023;147:718-727.
     PubMed     Abstract available
     
     
     
102. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
     Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
     Circulation. 2023;147:586-596.
     PubMed     Abstract available
     
     
     
103. LAWAL OD, Aronow HD, Shobayo F, Hume AL, et al
     Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
     Circulation. 2023 Feb 10. doi: 10.1161/CIRCULATIONAHA.122.060687.
     PubMed     Abstract available
     
     
     January 2023
104. HIGASHIKUNI Y, Liu W, Numata G, Tanaka K, et al
     NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
     Circulation. 2023;147:338-355.
     PubMed     Abstract available
     
     
     
105. HAGHIGHAT L, Goldschlager N, Oesterle A
     ECG Challenge: AV Block or Something Else?
     Circulation. 2023;147:267-270.
     PubMed    
     
     
     
106. YANG Z, Zhang CH, Li X
     What Is the Truth Behind Abnormal ECG Changes?
     Circulation. 2023;147:175-177.
     PubMed    
     
     
     December 2022
107. WEITZ JI, Eikelboom JW
     What Is the Future of Factor XI Inhibitors?
     Circulation. 2022;146:1899-1902.
     PubMed    
     
     
     
108. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
     Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
     Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
     PubMed     Abstract available
     
     
     
109. BERSELL KR, Yang T, Mosley JD, Glazer AM, et al
     Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
     Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.062193.
     PubMed     Abstract available
     
     
     
110. MARK ESTES NA, Jain S, Saba S
     Coronary Vasospasm With Pulse Field Ablation: Primum Non Nocere.
     Circulation. 2022;146:1820-1822.
     PubMed    
     
     
     
111. MARCUS GM
     Smartwatch-Detected Atrial Fibrillation: The "Value" in the Positive Predictive Value.
     Circulation. 2022;146:1733-1734.
     PubMed    
     
     
     
112. BENZ AP, Eikelboom JW
     Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned.
     Circulation. 2022;146:1746-1748.
     PubMed    
     
     
     
113. THIAGARAJAN N, Ho WHH, Lim DYZ, Loo WTW, et al
     Yield of Cardiac Magnetic Resonance Imaging in a Preparticipation Cohort of Young Asian Males With T Wave Inversion.
     Circulation. 2022;146:1802-1804.
     PubMed    
     
     
     November 2022
114. PRASAD P, Howell S, Sanghai S, Stecker E, et al
     Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation.
     Circulation. 2022;146:1730-1732.
     PubMed    
     
     
     
115. VALDERRABANO M, Fuentes Rojas SC, Lador A, Patel A, et al
     Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease.
     Circulation. 2022;146:1644-1656.
     PubMed     Abstract available
     
     
     
116. PRYSTOWSKY EN
     Rate Versus Rhythm Control for Atrial Fibrillation: Has the Debate Been Settled?
     Circulation. 2022;146:1561-1563.
     PubMed    
     
     
     
117. SCHINNER C, Xu L, Franz H, Zimmermann A, et al
     Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-alphaVbeta6/TGF-beta Signaling Cascade.
     Circulation. 2022;146:1610-1626.
     PubMed     Abstract available
     
     
     
118. ZHANG S, Liu S, Leach JP, Li K, et al
     Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction.
     Circulation. 2022;146:1558-1560.
     PubMed    
     
     
     
119. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
     Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
     Circulation. 2022;146:1461-1474.
     PubMed     Abstract available
     
     
     
120. HAN J, Husband G, Doppalapudi H
     Tachycardia Associated With Pacing.
     Circulation. 2022;146:1475-1477.
     PubMed    
     
     
     
121. KANAOKA K, Onoue K, Terasaki S, Nakano T, et al
     Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
     Circulation. 2022;146:1425-1433.
     PubMed     Abstract available
     
     
     
122. 
     Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
     Circulation. 2022;146:e279.
     PubMed    
     
     
     
123. POKORNEY SD, Chertow GM, Al-Khalidi HR, Gallup D, et al
     Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.121.054990.
     PubMed     Abstract available
     
     
     
124. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
     A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
     PubMed     Abstract available
     
     
     October 2022
125. VISKIN S, Chorin E, Schwartz AL, Kukla P, et al
     Arrhythmogenic Effects of Cardiac Memory.
     Circulation. 2022;146:1170-1181.
     PubMed     Abstract available
     
     
     
126. GASPERETTI A, Carrick RT, Costa S, Compagnucci P, et al
     Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
     Circulation. 2022 Oct 7:101161CIRCULATIONAHA122060866.
     PubMed     Abstract available
     
     
     September 2022
127. PATTEN RD, Shah SP
     Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis.
     Circulation. 2022;146:976-979.
     PubMed    
     
     
     
128. 
     Correction to: Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
     Circulation. 2022;146:e186.
     PubMed    
     
     
     
129. LUBITZ SA, Faranesh AZ, Selvaggi C, Atlas SJ, et al
     Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
     Circulation. 2022 Sep 23:101161CIRCULATIONAHA122060291.
     PubMed     Abstract available
     
     
     
130. REDDY VY, Petru J, Funasako M, Kopriva K, et al
     Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
     Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
     PubMed     Abstract available
     
     
     
131. AL-KHATIB SM, Wojdyla DM, Granger CB, Wallentin L, et al
     Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
     Circulation. 2022;146:958-960.
     PubMed    
     
     
     
132. TSAI CF, Chuang YT, Chang KW
     A Peculiar Wide Complex Tachycardia During Flecainide Treatment.
     Circulation. 2022;146:955-957.
     PubMed    
     
     
     
133. YANG E, Calkins H
     Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?
     Circulation. 2022;146:848-850.
     PubMed    
     
     
     
134. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
     Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
     Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
     PubMed     Abstract available
     
     
     August 2022
135. MEHRA R, Chung MK, Olshansky B, Dobrev D, et al
     Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association.
     Circulation. 2022;146:e119-e136.
     PubMed     Abstract available
     
     
     
136. ZHAO Y, Riching AS, Knight WE, Chi C, et al
     Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart.
     Circulation. 2022;146:699-714.
     PubMed     Abstract available
     
     
     
137. NORDENSWAN HK, Poyhonen P, Lehtonen J, Ekstrom K, et al
     Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
     Circulation. 2022 Aug 24:101161CIRCULATIONAHA121058120.
     PubMed     Abstract available
     
     
     
138. RADINOVIC A, Della Bella P
     Response by Radinovic and Della Bella to Letter Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
     Circulation. 2022;146:e71-e72.
     PubMed    
     
     
     
139. BENALI K, Guenancia C, Martins RP
     Letter by Benali et al Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
     Circulation. 2022;146:e69-e70.
     PubMed    
     
     
     
140. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
     Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
     Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
     PubMed     Abstract available
     
     
     July 2022
141. VAN DER STUIJT W, Smeding L, Olde Nordkamp LRA, Knops RE, et al
     Response by van der Stuijt et al to Letter Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
     Circulation. 2022;146:e10-e11.
     PubMed    
     
     
     
142. MADIAS C, Madias JE
     Letter by Madias and Madias Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial".
     Circulation. 2022;146:e8-e9.
     PubMed    
     
     
     
143. REDDY YNV, Borlaug BA, Gersh BJ
     Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
     Circulation. 2022;146:339-357.
     PubMed     Abstract available
     
     
     
144. ESSIEN UR, Johnson AE
     Whose Streets? Neighborhood-Level Determinants of Atrial Fibrillation Care.
     Circulation. 2022;146:172-174.
     PubMed    
     
     
     
145. SHAH RA, Asatryan B, Sharaf Dabbagh G, Aung N, et al
     Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
     Circulation. 2022;146:110-124.
     PubMed     Abstract available
     
     
     
146. TONG D, Schiattarella GG, Jiang N, Daou D, et al
     Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation.
     Circulation. 2022;146:73-76.
     PubMed    
     
     
     June 2022
147. AVENDANO R, Lavi N, Rosenfeld LE
     Around and Around...A Wide Complex Tachycardia.
     Circulation. 2022;145:1867-1869.
     PubMed    
     
     
     
148. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
     Can Early Ablation of Ventricular Tachycardia Improve Survival?
     Circulation. 2022;145:1850-1852.
     PubMed    
     
     
     
149. TUNG R, Xue Y, Chen M, Jiang C, et al
     First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
     Circulation. 2022;145:1839-1849.
     PubMed     Abstract available
     
     
     
150. CHEW DS, Li Y, Cowper PA, Anstrom KJ, et al
     Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
     Circulation. 2022 Jun 21:101161CIRCULATIONAHA122058575.
     PubMed     Abstract available
     
     
     
151. MORGAN E, Anderson J, Noheria A
     Premature Complexes and Blocked P Wave.
     Circulation. 2022;145:1803-1805.
     PubMed    
     
     
     
152. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
     Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
     Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
     PubMed     Abstract available
     
     
     
153. POKORNEY SD, Granger CB
     Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure.
     Circulation. 2022;145:1705-1707.
     PubMed    
     
     
     May 2022
154. MAQSOOD N, Cooper JM, Whitman IR
     Letter by Maqsood et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
     Circulation. 2022;145:e1054-e1055.
     PubMed    
     
     
     
155. IBRAHIM OA, Belley-Cote EP, McIntyre WF
     Letter by Ibrahim et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
     Circulation. 2022;145:e1056.
     PubMed    
     
     
     
156. SCHMIDT AS, Lauridsen KG, Albertsen AE, Lofgren B, et al
     Response to Letters Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
     Circulation. 2022;145:e1057-e1058.
     PubMed    
     
     
     
157. NAUFFAL V, Morrill VN, Jurgens SJ, Choi SH, et al
     Monogenic and Polygenic Contributions to QTc Prolongation in the Population.
     Circulation. 2022;145:1524-1533.
     PubMed     Abstract available
     
     
     
158. VAN OPBERGEN CJM, Bagwan N, Maurya SR, Kim JC, et al
     Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2-Deficient Hearts.
     Circulation. 2022;145:1480-1496.
     PubMed     Abstract available
     
     
     
159. GROENEVELD SA, van der Ree MH, Mulder BA, Balt J, et al
     Prevalence of Short-Coupled Ventricular Fibrillation in a Large Cohort of Dutch Patients With Idiopathic Ventricular Fibrillation.
     Circulation. 2022;145:1437-1439.
     PubMed    
     
     
     April 2022
160. NATALE A, Kar S, Holmes D
     Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
     Circulation. 2022;145:e847-e848.
     PubMed    
     
     
     
161. PRICE MJ, Gibson DN, Kar S
     Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
     Circulation. 2022;145:e849.
     PubMed    
     
     
     
162. DHRUVA SS, Redberg RF
     Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
     Circulation. 2022;145:e845-e846.
     PubMed    
     
     
     
163. HOCHSTADT A, Rosso R, Viskin S
     Sinus Node Dysfunction With a Nice Twist.
     Circulation. 2022;145:1285-1287.
     PubMed    
     
     
     
164. 
     Correction to: Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
     Circulation. 2022;145:e842.
     PubMed    
     
     
     
165. FATKIN D, Cox CD, Martinac B
     Fishing for Links Between Omega-3 Fatty Acids and Atrial Fibrillation.
     Circulation. 2022;145:1037-1039.
     PubMed    
     
     
     
166. DELLA BELLA P, Baratto F, Vergara P, Bertocchi P, et al
     Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
     Circulation. 2022 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.059598.
     PubMed     Abstract available
     
     
     March 2022
167. EXTRAMIANA F, Steg PG
     Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It?
     Circulation. 2022;145:955-958.
     PubMed    
     
     
     
168. MUGNAI G, Gambaro A, Ribichini FL
     A Tachycardia in Disguise.
     Circulation. 2022;145:1024-1028.
     PubMed    
     
     
     
169. PARKASH R, Wells GA, Rouleau J, Talajic M, et al
     Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.
     Circulation. 2022 Mar 22. doi: 10.1161/CIRCULATIONAHA.121.057095.
     PubMed     Abstract available
     
     
     
170. WALSH R, Bezzina C, Wilde AAM
     First Steps of Population Genomic Medicine in the Arrhythmia World: Pros and Cons.
     Circulation. 2022;145:892-895.
     PubMed    
     
     
     
171. GLAZER AM, Davogustto G, Shaffer CM, Vanoye CG, et al
     Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
     Circulation. 2022;145:877-891.
     PubMed     Abstract available
     
     
     
172. ANDRADE JG, Macle L
     Atrial Fibrillation Ablation: Aiming to Improve Quantity and Quality of Life.
     Circulation. 2022;145:805-807.
     PubMed    
     
     
     
173. TANG Y, Zhang Y, Yang XY
     Rare Case of Wide QRS Tachycardia After Sintilimab Treatment for Lung Cancer.
     Circulation. 2022;145:783-786.
     PubMed    
     
     
     
174. KOWALEWSKI C, Dagres N, Hindricks G
     Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
     Circulation. 2022;145:739-741.
     PubMed    
     
     
     
175. BOAS R, Sappler N, von Stulpnagel L, Klemm M, et al
     Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
     Circulation. 2022;145:754-764.
     PubMed     Abstract available
     
     
     
176. GALEA R, De Marco F, Meneveau N, Aminian A, et al
     Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
     Circulation. 2022;145:724-738.
     PubMed     Abstract available
     
     
     
177. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
     Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
     Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
     PubMed     Abstract available
     
     
     
178. YOSHIDA T, Nakamura A, Funada J, Amino M, et al
     Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial.
     Circulation. 2022;145:718-720.
     PubMed    
     
     
     February 2022
179. 
     Correction to: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
     Circulation. 2022;145:e640.
     PubMed    
     
     
     
180. VAN OUWERKERK AF, Bosada FM, van Duijvenboden K, Houweling AC, et al
     Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
     Circulation. 2022;145:606-619.
     PubMed     Abstract available
     
     
     
181. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
     MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
     Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
     PubMed     Abstract available
     
     
     
182. RIVARD L, Friberg L, Conen D, Healey JS, et al
     Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
     Circulation. 2022;145:392-409.
     PubMed     Abstract available
     
     
     
183. PELTENBURG PJ, Kallas D, Bos JM, Lieve KVV, et al
     An International Multicenter Cohort Study on beta-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
     Circulation. 2022;145:333-344.
     PubMed     Abstract available
     
     
     
184. KNOPS RE, van der Stuijt W, Delnoy PPHM, Boersma LVA, et al
     Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
     Circulation. 2022;145:321-329.
     PubMed     Abstract available
     
     
     January 2022
185. GOTO S, Goto S
     A Patient-Level Meta-Analysis: The End of the Era of Direct Oral Anticoagulant Developmental Trials in Patients With Atrial Fibrillation?
     Circulation. 2022;145:256-258.
     PubMed    
     
     
     
186. WADA Y, Yang T, Shaffer CM, Daniel LL, et al
     Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.
     Circulation. 2022;145:299-308.
     PubMed     Abstract available
     
     
     
187. CARNICELLI AP, Hong H, Connolly SJ, Eikelboom J, et al
     Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex.
     Circulation. 2022 Jan 5. doi: 10.1161/CIRCULATIONAHA.121.056355.
     PubMed     Abstract available
     
     
     December 2021
188. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
     Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
     Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
     PubMed     Abstract available
     
     
     
189. SAMUEL M, Nattel S
     Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?
     Circulation. 2021;144:1991-1994.
     PubMed    
     
     
     
190. MIRANDA-ARBOLEDA AF, Mohammad S, Baranchuk A
     Wide Complex Tachycardia and Syncope in the Emergency Department.
     Circulation. 2021;144:2040-2042.
     PubMed    
     
     
     
191. STEINBERG C, Dognin N, Sodhi A, Champagne C, et al
     Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD-II study).
     Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.056471.
     PubMed     Abstract available
     
     
     
192. WARD-CAVINESS CK
     Accelerated Epigenetic Aging and Incident Atrial Fibrillation: New Outlook on an Immutable Risk Factor?
     Circulation. 2021;144:1912-1914.
     PubMed    
     
     
     November 2021
193. HANKEY GJ
     Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
     Circulation. 2021;144:1747-1749.
     PubMed    
     
     
     
194. FINOCCHIARO G, Westaby J, Bhatia R, Malhotra A, et al
     Sudden Death in Female Athletes: Insights From a Large Regional Registry in the United Kingdom.
     Circulation. 2021;144:1827-1829.
     PubMed    
     
     
     
195. SASMITA BR, Luo S, Huang B
     Wide and Narrow QRS Complex Tachycardia With Cycle Length Alternans: What Is the Mechanism?
     Circulation. 2021;144:1824-1826.
     PubMed    
     
     
     
196. AGUILAR M, Macle L, Deyell MW, Yao R, et al
     The Influence of Monitoring Strategy on Assessment of Ablation Success and Post-ablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.
     Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056109.
     PubMed     Abstract available
     
     
     
197. SCHMIDT AS, Lauridsen KG, Moller DS, Christensen PD, et al
     Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation.
     Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056301.
     PubMed     Abstract available
     
     
     
198. BERTERO E, Nickel A, Kohlhaas M, Hohl M, et al
     Loss of Mitochondrial Ca(2+) Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy.
     Circulation. 2021;144:1694-1713.
     PubMed     Abstract available
     
     
     
199. KIRCHHOF P
     In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
     Circulation. 2021;144:1587-1589.
     PubMed    
     
     
     
200. KHURSHID S, Friedman S, Reeder C, Di Achille P, et al
     Electrocardiogram-based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
     Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057480.
     PubMed     Abstract available
     
     
     
201. ROMANI F, Monasky MM, Pappone C
     Letter by Romani et al Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
     Circulation. 2021;144:e280-e281.
     PubMed    
     
     
     
202. LEOR J, Ram E, Naftali-Shani N, Shaihov-Teper O, et al
     Response by Leor et al to Letter Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
     Circulation. 2021;144:e282.
     PubMed    
     
     
     October 2021
203. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
     Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
     Circulation. 2021;144:1449-1451.
     PubMed    
     
     
     
204. BELHASSEN B, Shauer A, Biton Y
     Left Bundle-Branch Block Tachycardia After Transcatheter Aortic Valve Replacement.
     Circulation. 2021;144:1444-1448.
     PubMed    
     
     
     
205. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
     Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
     Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
     PubMed     Abstract available
     
     
     
206. HIGUCHI S, Goldschlager N, Gerstenfeld EP
     Atrioventricular Block With Narrow and Wide QRS: The Pause That Refreshes.
     Circulation. 2021;144:1262-1264.
     PubMed    
     
     
     
207. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
     Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
     Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
     PubMed     Abstract available
     
     
     September 2021
208. ROBERTS JD, Vittinghoff E, Lu AT, Alonso A, et al
     Epigenetic Age and the Risk of Incident Atrial Fibrillation.
     Circulation. 2021 Sep 30. doi: 10.1161/CIRCULATIONAHA.121.056456.
     PubMed     Abstract available
     
     
     
209. HULSURKAR MM, Lahiri SK, Moore O, Moreira LM, et al
     Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation.
     Circulation. 2021;144:909-912.
     PubMed    
     
     
     
210. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
     Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy.
     Circulation. 2021;144:823-839.
     PubMed     Abstract available
     
     
     
211. SUN Z, Wang L, Han L, Wang Y, et al
     Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia.
     Circulation. 2021;144:788-804.
     PubMed     Abstract available
     
     
     August 2021
212. MACHEREY S, Sinning JM, Mauri V
     Wide QRS Complex Bradycardia in a Hemodynamically Unstable Young Woman.
     Circulation. 2021;144:659-661.
     PubMed    
     
     
     
213. AN ZY, Peng D, Shi YJ
     A Patient With Acute Shortness of Breath and Inferior ST-Segment Elevation: A Diagnostic Trap.
     Circulation. 2021;144:577-579.
     PubMed    
     
     
     
214. RAAD N, Bittihn P, Cacheux M, Jeong D, et al
     Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
     Circulation. 2021;144:441-454.
     PubMed     Abstract available
     
     
     
215. CHEANG S, LeLorier P, Gajewski K
     Diffuse ST-Segment Elevation With Idiopathic Malignant Ventricular Arrhythmia.
     Circulation. 2021;144:399-402.
     PubMed    
     
     
     July 2021
216. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
     Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
     Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
     PubMed     Abstract available
     
     
     
217. REAL C, Morales T, Viana-Tejedor A
     An Unusual Call From the Urology Ward.
     Circulation. 2021;144:324-327.
     PubMed    
     
     
     
218. FRADLEY MG, Beckie TM, Brown SA, Cheng RK, et al
     Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.
     Circulation. 2021;144:e41-e55.
     PubMed     Abstract available
     
     
     
219. FELKER GM, Butler J, Ibrahim NE, Pina IL, et al
     Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
     Circulation. 2021;144:180-182.
     PubMed    
     
     
     
220. VISKIN S, Marai I, Rosso R
     Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
     Circulation. 2021;144:85-89.
     PubMed    
     
     
     June 2021
221. PASSMAN R
     "Pill-in-Pocket" Anticoagulation for Atrial Fibrillation: Fiction, Fact, or Foolish?
     Circulation. 2021;143:2211-2213.
     PubMed    
     
     
     
222. BHASIN D, Kumar R, Gupta A
     A Young Woman With Palpitations: A Poison or a Remedy?
     Circulation. 2021;143:2312-2315.
     PubMed    
     
     
     
223. BOULET J, Massie E, Liszkowski M
     A Silent Arrhythmia: How Would You Manage This Patient?
     Circulation. 2021;143:2205-2207.
     PubMed    
     
     
     May 2021
224. SINGH M, Joglar J
     Morbidly Obese Patients With Symptomatic Atrial Fibrillation: Why Are We Holding Back on Bariatric Surgery?
     Circulation. 2021;143:1838-1840.
     PubMed    
     
     
     
225. WALDMANN V, Combes N, Narayanan K, Marijon E, et al
     Response by Waldmann et al to Letter Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
     Circulation. 2021;143:e900-e901.
     PubMed    
     
     
     
226. FERRERO P, Chessa M
     Letter by Ferrero and Chessa Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
     Circulation. 2021;143:e898-e899.
     PubMed    
     
     
     April 2021
227. GILLIS AM, Wilton SB
     Rhythm Control of Atrial Fibrillation: The Earlier the Better?
     Circulation. 2021;143:1639-1641.
     PubMed    
     
     
     
228. KANEKO H, Yano Y, Itoh H, Morita K, et al
     Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
     Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
     PubMed     Abstract available
     
     
     
229. RANSOM JL, Wong KC
     Palpitations in the Clinic.
     Circulation. 2021;143:1631-1634.
     PubMed    
     
     
     
230. BENZ AP, Hijazi Z, Lindback J, Connolly SJ, et al
     Biomarker-Based Risk Prediction With The ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
     Circulation. 2021 Apr 14. doi: 10.1161/CIRCULATIONAHA.120.053100.
     PubMed     Abstract available
     
     
     
231. DAI XC, An ZY
     Severe Arrhythmia Caused by a Chinese Herb Liquor: What Is the Diagnosis?
     Circulation. 2021;143:1450-1451.
     PubMed    
     
     
     March 2021
232. GIUDICESSI JR, Schram M, Bos JM, Galloway CD, et al
     Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
     Circulation. 2021;143:1274-1286.
     PubMed     Abstract available
     
     
     
233. ROSENBERG MA
     Trusting Magic: Interpretability of Predictions From Machine Learning Algorithms.
     Circulation. 2021;143:1299-1301.
     PubMed    
     
     
     
234. PENG D, Liu X, Pan Y
     Irregular Complex Tachycardia: Not Dual Atrioventricular Nodal Nonreentrant Tachycardia.
     Circulation. 2021;143:1173-1176.
     PubMed    
     
     
     
235. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
     Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
     Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
     PubMed     Abstract available
     
     
     
236. PILLAI A, Ellenbogen KA, Padala SK
     A Tale of 2 Blocks.
     Circulation. 2021;143:1062-1065.
     PubMed    
     
     
     February 2021
237. ARAS D, Ozeke O, Topaloglu S
     When You Hear Hoofbeats, Look for Horses, Not Zebras.
     Circulation. 2021;143:862-864.
     PubMed    
     
     
     
238. WORKMAN V, Forrest JK, Enriquez A
     A Case of Presyncope After Transcatheter Aortic Valve Replacement.
     Circulation. 2021;143:857-861.
     PubMed    
     
     
     
239. YAMAGUCHI N, Xiao J, Narke D, Shaheen D, et al
     Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.
     Circulation. 2021;143:805-820.
     PubMed     Abstract available
     
     
     
240. KARABINOS I, Kostaki P, Panagopoulos Z
     Bizarre Downsloping ST Segment Elevation Challenge.
     Circulation. 2021;143:599-601.
     PubMed    
     
     
     
241. CHEN AY, Nishimura T, Tung R
     Narrowing the Differential Diagnosis for a Wide Complex Tachycardia.
     Circulation. 2021;143:503-506.
     PubMed    
     
     
     January 2021
242. TOMCSANYI J, Paulik R, Fresz T
     Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
     Circulation. 2021;143:397-400.
     PubMed    
     
     
     
243. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
     The Heart Rate of Ventricular Tachycardia.
     Circulation. 2021;143:227-229.
     PubMed    
     
     
     
244. NISHIMURA T, Upadhyay GA, Aziz ZA, Beaser AD, et al
     Circuit Determinants of Ventricular Tachycardia Cycle Length: Characterization of Fast and Unstable Human Ventricular Tachycardia.
     Circulation. 2021;143:212-226.
     PubMed     Abstract available
     
     
     
245. GOLD MR, Lambiase PD, El-Chami MF, Knops RE, et al
     Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
     Circulation. 2021;143:7-17.
     PubMed     Abstract available
     
     
     December 2020
246. PAL N, Padala S, Klein K
     Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e501-e502.
     PubMed    
     
     
     
247. BELLEY-COTE EP, Whitlock RP
     Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e503.
     PubMed    
     
     
     
248. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
     Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e504-e505.
     PubMed    
     
     
     October 2020
249. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
     Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     
250. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
     Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     PubMed     Abstract available
     
     
     June 2020
251. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
     Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
     Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.